| Primary |
| Product Used For Unknown Indication |
20.8% |
| Pain |
14.4% |
| Back Pain |
7.9% |
| Osteoarthritis |
7.9% |
| Osteoporosis |
5.9% |
| Myalgia |
5.4% |
| Hypermobility Syndrome |
5.0% |
| Rheumatoid Arthritis |
5.0% |
| Headache |
4.0% |
| Musculoskeletal Pain |
3.5% |
| Analgesic Therapy |
3.0% |
| Pregnancy |
2.5% |
| Symphysiolysis |
2.5% |
| Arthralgia |
2.0% |
| Psoriatic Arthropathy |
2.0% |
| Type 2 Diabetes Mellitus |
2.0% |
| Vitamin B12 Deficiency |
2.0% |
| Periarthritis |
1.5% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.5% |
| Renal Cancer Metastatic |
1.5% |
|
| Withdrawal Syndrome |
12.5% |
| Tremor |
9.4% |
| Vomiting |
9.4% |
| Respiratory Depression |
6.3% |
| Somnolence |
6.3% |
| Suicidal Ideation |
6.3% |
| Syncope |
6.3% |
| Dizziness |
4.7% |
| Visual Acuity Reduced |
4.7% |
| Drug Administration Error |
3.1% |
| Drug Ineffective |
3.1% |
| Feeling Abnormal |
3.1% |
| Gastroenteritis Viral |
3.1% |
| Local Swelling |
3.1% |
| Nausea |
3.1% |
| Pelvic Pain |
3.1% |
| Thirst |
3.1% |
| Toxicity To Various Agents |
3.1% |
| Urinary Retention |
3.1% |
| Weight Increased |
3.1% |
|
| Secondary |
| Pain |
15.4% |
| Rheumatoid Arthritis |
14.7% |
| Osteoarthritis |
14.1% |
| Myalgia |
14.1% |
| Osteoporosis |
13.9% |
| Hypermobility Syndrome |
13.7% |
| Intentional Overdose |
3.3% |
| Drug Use For Unknown Indication |
3.2% |
| Product Used For Unknown Indication |
2.9% |
| Hypertension |
0.6% |
| Cancer Pain |
0.6% |
| Anaesthesia |
0.5% |
| Back Pain |
0.4% |
| Depression |
0.4% |
| Asthma |
0.4% |
| Muscle Relaxant Therapy |
0.4% |
| Cardiovascular Disorder |
0.3% |
| Duodenal Ulcer |
0.3% |
| Overdose Deliberate Self-inflicted |
0.3% |
| Drug Exposure During Pregnancy |
0.3% |
|
| Suicidal Ideation |
44.3% |
| Vascular Anomaly |
8.2% |
| Stubbornness |
6.7% |
| Vomiting |
5.2% |
| Syncope |
4.1% |
| Overdose |
3.6% |
| Renal Failure |
3.6% |
| Withdrawal Syndrome |
3.6% |
| Thirst |
2.6% |
| Feeling Abnormal |
2.1% |
| Pelvic Deformity |
2.1% |
| Pelvic Pain |
2.1% |
| Toxicity To Various Agents |
2.1% |
| Dizziness |
1.5% |
| Hip Dysplasia |
1.5% |
| Intra-uterine Death |
1.5% |
| Metabolic Acidosis |
1.5% |
| Urinary Incontinence |
1.5% |
| Acquired Haemophilia |
1.0% |
| Acute Hepatic Failure |
1.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
52.0% |
| Drug Use For Unknown Indication |
12.2% |
| Rheumatoid Arthritis |
7.0% |
| Pain |
5.6% |
| Hypertension |
3.3% |
| Back Pain |
2.4% |
| Depression |
2.2% |
| Osteoarthritis |
1.9% |
| Prophylaxis |
1.4% |
| Neuralgia |
1.4% |
| Osteoporosis |
1.4% |
| Infection |
1.2% |
| Arthralgia |
1.2% |
| Asthma |
1.2% |
| Psoriasis |
1.1% |
| Nausea |
1.0% |
| Diabetes Mellitus |
0.9% |
| Type 2 Diabetes Mellitus |
0.9% |
| Anxiety |
0.8% |
| B-cell Lymphoma |
0.8% |
|
| Vomiting |
16.1% |
| Thrombocytopenia |
6.1% |
| Tremor |
6.1% |
| Renal Failure Acute |
5.8% |
| Haematemesis |
5.3% |
| Malaise |
5.3% |
| Sepsis |
5.0% |
| Somnolence |
4.7% |
| Urinary Tract Infection |
4.5% |
| Liver Function Test Abnormal |
4.2% |
| Pneumonia |
4.2% |
| Swelling Face |
4.2% |
| Gastrointestinal Haemorrhage |
3.9% |
| Renal Impairment |
3.7% |
| Visual Impairment |
3.7% |
| Weight Decreased |
3.7% |
| Myalgia |
3.4% |
| Rash |
3.4% |
| Skin Exfoliation |
3.4% |
| Syncope |
3.4% |
|
| Interacting |
| Product Used For Unknown Indication |
40.0% |
| Limb Injury |
26.7% |
| Pain |
20.0% |
| Analgesic Therapy |
6.7% |
| Contraception |
6.7% |
|
| Feeling Abnormal |
16.7% |
| Loss Of Consciousness |
16.7% |
| Nausea |
16.7% |
| Pain |
16.7% |
| Pregnancy |
16.7% |
| Vomiting |
16.7% |
|
